Tip Card: Ninlaro® (ixazomib) (https://www.myeloma.org/resource-library/tip-card-ninlaror-ixazomib)
This proteasome inhibitor is indicated for patients with myeloma who have received at least one prior therapy.
This proteasome inhibitor is indicated for patients with myeloma who have received at least one prior therapy.